A Prospective Study of Outcome After Therapy for Acromegaly

CompletedOBSERVATIONAL
Enrollment

280

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

August 31, 2025

Study Completion Date

August 31, 2025

Conditions
Acromegaly
Interventions
PROCEDURE

Surgery for acromegaly

(non-experimental) standard procedure

DRUG

Medications for acromegaly

(non-experimental) standard procedure

DIAGNOSTIC_TEST

Total body magnetic resonance imaging

Subjects will undergo total body MRI with spectroscopy of the muscle and liver before and 3-6 months, 12 and 24 months after surgery or medical therapy for acromegaly.

PROCEDURE

Adipose Tissue Biopsy

Subjects will undergo biopsy of subcutaneous adipose tissue before and 12 and 24 months after surgery or medical therapy for acromegaly.

Trial Locations (1)

10032

Neuroendocrine Unit; Columbia University Medical Center, 180 Fort Washington Avenue 9-970, New York

All Listed Sponsors
collaborator

Icahn School of Medicine at Mount Sinai

OTHER

collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Columbia University

OTHER

NCT01809808 - A Prospective Study of Outcome After Therapy for Acromegaly | Biotech Hunter | Biotech Hunter